DK165901C - Stabiliserede injektionsoploesninger af piroxicam - Google Patents

Stabiliserede injektionsoploesninger af piroxicam

Info

Publication number
DK165901C
DK165901C DK461385A DK461385A DK165901C DK 165901 C DK165901 C DK 165901C DK 461385 A DK461385 A DK 461385A DK 461385 A DK461385 A DK 461385A DK 165901 C DK165901 C DK 165901C
Authority
DK
Denmark
Prior art keywords
piroxicam
solutions
injection solutions
stabilized injection
stabilized
Prior art date
Application number
DK461385A
Other languages
Danish (da)
English (en)
Other versions
DK461385D0 (da
DK165901B (da
DK461385A (da
Inventor
Walter Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of DK461385D0 publication Critical patent/DK461385D0/da
Publication of DK461385A publication Critical patent/DK461385A/da
Publication of DK165901B publication Critical patent/DK165901B/da
Application granted granted Critical
Publication of DK165901C publication Critical patent/DK165901C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK461385A 1984-10-10 1985-10-09 Stabiliserede injektionsoploesninger af piroxicam DK165901C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843437232 DE3437232A1 (de) 1984-10-10 1984-10-10 Stabilisierte injektionsloesungen von piroxicam
DE3437232 1984-10-10

Publications (4)

Publication Number Publication Date
DK461385D0 DK461385D0 (da) 1985-10-09
DK461385A DK461385A (da) 1986-04-11
DK165901B DK165901B (da) 1993-02-08
DK165901C true DK165901C (da) 1993-06-28

Family

ID=6247603

Family Applications (1)

Application Number Title Priority Date Filing Date
DK461385A DK165901C (da) 1984-10-10 1985-10-09 Stabiliserede injektionsoploesninger af piroxicam

Country Status (22)

Country Link
US (1) US4628053A (enExample)
EP (1) EP0177870B1 (enExample)
JP (1) JPS6191116A (enExample)
KR (1) KR890001001B1 (enExample)
CN (1) CN85107838B (enExample)
AT (1) ATE62416T1 (enExample)
AU (1) AU557184B2 (enExample)
CA (1) CA1251734A (enExample)
DD (1) DD238329A5 (enExample)
DE (2) DE3437232A1 (enExample)
DK (1) DK165901C (enExample)
FI (1) FI84315C (enExample)
GR (1) GR852439B (enExample)
HU (1) HU195111B (enExample)
IE (1) IE58267B1 (enExample)
IL (1) IL76624A0 (enExample)
NO (1) NO166687C (enExample)
NZ (1) NZ213758A (enExample)
PH (1) PH23058A (enExample)
PT (1) PT81264B (enExample)
SU (1) SU1482509A3 (enExample)
ZA (1) ZA857783B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545910B1 (fr) * 1983-05-11 1988-07-22 Valeo Dispositif pour ameliorer l'efficacite d'un echangeur de chaleur dans un boitier d'une installation de climatisation, et boitier de cette installation
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
WO1998001138A1 (fr) * 1996-07-04 1998-01-15 Nippon Kayaku Kabushiki Kaisha Injections de succinate sodique de methylprednisolone
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8314124B2 (en) * 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
SG10201508623RA (en) * 2005-10-19 2015-11-27 Teva Pharma Crystals of laquinimod sodium, and process for the manufacture thereof
KR20150065951A (ko) * 2006-06-12 2015-06-15 테바 파마슈티컬 인더스트리즈 리미티드 안정한 라퀴니모드 제제
WO2009082471A1 (en) * 2007-12-20 2009-07-02 Teva Pharmaceutical Industries, Ltd. Stable laquinimod preparations
MX2011002033A (es) * 2008-09-03 2011-05-02 Teva Pharma 2-oxo-1,2-dihidro-quinolinas moduladoras de la funcion inmune.
JP5359333B2 (ja) * 2009-02-05 2013-12-04 ゼリア新薬工業株式会社 コロソリン酸含有水性液剤
ES2564931T3 (es) * 2009-07-30 2016-03-30 Teva Pharmaceutical Industries Ltd. Tratamiento de enfermedad de Crohn con laquinimod
CA2771203C (en) * 2009-08-10 2019-04-09 Teva Pharmaceutical Industries Ltd. Treatment of bdnf-related disorders using laquinimod
MX2012004177A (es) 2009-10-12 2012-05-08 Boehringer Ingelheim Vetmed Recipiente para composiciones que comprenden meloxicam.
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EP2766020A4 (en) 2011-10-12 2015-04-01 Teva Pharma TREATMENT OF MULTIPLE SCLEROSIS BY COMBINING LAQUINIMOD AND FINGOLIMOD
AR089862A1 (es) 2012-02-03 2014-09-24 Teva Pharma USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
MX2015005632A (es) 2012-11-07 2016-02-05 Teva Pharma Sales de amina de laquinimod.
EP2970129A2 (en) 2013-03-14 2016-01-20 Teva Pharmaceutical Industries Ltd. Crystals of laquinimod sodium and improved process for the manufacture thereof
KR101749425B1 (ko) * 2015-11-17 2017-06-22 연세대학교 산학협력단 난용성 약물의 서방형 제제
FI3664800T3 (fi) * 2017-08-09 2024-08-07 Dechra Veterinary Products Llc Cox-2-estäjää käsittäviä terapeuttisia formulaatioita ja niiden käyttötarkoituksia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629650A (enExample) * 1967-05-18 1900-01-01
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung

Also Published As

Publication number Publication date
NZ213758A (en) 1988-07-28
EP0177870A3 (en) 1987-06-03
EP0177870A2 (de) 1986-04-16
PT81264A (en) 1985-11-01
FI84315C (fi) 1991-11-25
JPS6191116A (ja) 1986-05-09
PT81264B (pt) 1988-02-17
ZA857783B (en) 1987-05-27
DK461385D0 (da) 1985-10-09
IE58267B1 (en) 1993-08-25
NO854011L (no) 1986-04-11
GR852439B (enExample) 1986-02-10
NO166687B (no) 1991-05-21
CN85107838A (zh) 1986-07-09
DE3437232A1 (de) 1986-04-17
IE852483L (en) 1986-04-10
CN85107838B (zh) 1988-08-24
CA1251734A (en) 1989-03-28
IL76624A0 (en) 1986-02-28
DD238329A5 (de) 1986-08-20
FI853926A0 (fi) 1985-10-09
DK165901B (da) 1993-02-08
DK461385A (da) 1986-04-11
AU557184B2 (en) 1986-12-11
HUT38541A (en) 1986-06-30
NO166687C (no) 1991-09-04
US4628053A (en) 1986-12-09
FI84315B (fi) 1991-08-15
HU195111B (en) 1988-04-28
ATE62416T1 (de) 1991-04-15
PH23058A (en) 1989-03-27
KR860003013A (ko) 1986-05-19
EP0177870B1 (de) 1991-04-10
AU4842185A (en) 1986-04-17
SU1482509A3 (ru) 1989-05-23
FI853926L (fi) 1986-04-11
DE3582468D1 (de) 1991-05-16
KR890001001B1 (ko) 1989-04-18
JPH03849B2 (enExample) 1991-01-09

Similar Documents

Publication Publication Date Title
DK461385D0 (da) Stabiliserede injicerbare oploesninger af piroxicam
SE8402560D0 (sv) Farmaceutisk komposition
ATE47715T1 (de) Stabile salze von sam mit polyanionen.
IT8119321A0 (it) Procedimento per ottenere eparine di basso peso molecolare dotate di proprieta' farmacologiche elevate, e prodotto cosi' ottenuto.
FR2518088B1 (fr) Nouveaux derives d'aminoacides, et leur application therapeutique
FI934000A0 (fi) Nya estrar av bi- och tricykliska aminoalkoholer, deras framstaellning och deras anvaendning i laekemedel
FI844677A0 (fi) Komposition och metod foer snabb upptaeckt av mikroorganismer i kliniska prover.
IE831611L (en) Topical anti-inflammatory compositions
DE3768419D1 (de) Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
ATE159250T1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
ATE65401T1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
SE8600658D0 (sv) Novel composition of matter
ES8400430A1 (es) "un procedimiento para la preparacion de derivados piperacinicos de la teobromina".
SE8902607L (sv) Oxaza heterocykler och pharmaceutiska kompositioner innehaallande densamma
GB985773A (en) Improvements in or relating to coated medicinals
IT8219587A0 (it) Derivati di apovincaminolo, relativo procedimento di preparazione e composizioni farmaceutiche contenenti glistessi.
ATE19077T1 (de) Thiophen-derivat mit mucoregulatorischer und anti-husten-wirkung, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
CH585224A5 (en) Central-inhibitory and neuroleptic fluoro- tricyclic cpds. - prepd. by reacting a 10-halo-fluoro-substd. dibenzothiepin with a substd piperazine
ATE29214T1 (de) Topische antiinflammatorische mittel.
DE3672635D1 (de) Esterderivate von 2,2-dimethyl-3-ethenylcyclopropancarbonsaeure, ihre herstellung, ihre verwendung als parasitizide und sie enthaltende zusammensetzungen.
ATE1011T1 (de) 5-fluoruracil-derivate, deren herstellung und ihre pharmazeutischen zusammensetzungen.

Legal Events

Date Code Title Description
PBP Patent lapsed